Scientific work

Prof. Dr. Bekir Uçan

172 publications. The source of the information is stated next to each publication.

Back to profile

  1. Clinical, hormonal, and treatment outcomes in 247 patients with acromegaly: a single tertiary center experience

    Turkish Journal of Medical Sciences, 2026

    DOI 10.55730/1300-0144.6205 PMID 42499429 Open-access full textSource: ORCID

  2. Effect of Intraoperative Nerve Monitorization on Predicting Vocal Cord Paralysis in Thyroid Surgery

    International Archives of Otorhinolaryngology, 2026

    DOI 10.1055/s-0045-1810079 PMID 41821955 Open-access full textSource: ORCID

  3. Clinicopathological predictors of central lymph node metastasis in clinically node-negative papillary thyroid carcinoma: a retrospective cohort analysis

    European Archives of Oto-Rhino-Laryngology, 2026

    DOI 10.1007/s00405-025-09878-9 PMID 41288698 1 citation (Europe PMC) Source: ORCID

  4. Gonadal recovery in men with prolactinomas on cabergoline: 6-month testosterone levels as a predictor of testosterone replacement timing

    Hormones, 2026

    DOI 10.1007/s42000-026-00766-3 PMID 41926073 Source: ORCID

  5. Identification of High-Risk Individuals for Osteoporosis and Fragility Fractures in Cushing's Syndrome: A Promising Predictive Approach

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15062442 PMID 41899363 Open-access full textSource: ORCID

  6. Increased prevalence of abdominal aortic aneurysm in biochemically confirmed primary aldosteronism: a new complication?

    Endocrine, 2026

    DOI 10.1007/s12020-026-04650-3 PMID 42081031 Source: ORCID

  7. Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission

    Frontiers in Endocrinology, 2026

    DOI 10.3389/fendo.2026.1790066 PMID 42109743 2 citations (Europe PMC) Open-access full textSource: ORCID

  8. Reevaluating the Need for Routine IGF-1 Screening in Poorly Controlled Type 2 Diabetes Mellitus

    Endocrinology, Diabetes & Metabolism, 2026

    DOI 10.1002/edm2.70194 PMID 41878803 Open-access full textSource: ORCID

  9. Adrenal Rest Tumors and the clinical course of gonadal dysfunction in adult men with Congenital Adrenal Hyperplasia caused by 21-Hydroxylase Deficiency: A single-center experience with long-term follow-up

    Endocrine, 2026

    DOI 10.1007/s12020-026-04801-6 PMID 42804041 Source: Europe PMC

  10. Short-Term Real-World Clinical Outcomes of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes

    Gazi Medical Journal, 2026

    DOI 10.12996/gmj.2026.4631 Open-access full textSource: OpenAlex

  11. NE07 A simple clinical and biochemical prediction score for distinguishing ectopic ACTH syndrome from Cushing disease

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag128.051 Open-access full textSource: OpenAlex

  12. EP1457 - ECE_3005 - Factors associated with recurrence and persistent disease in subacute thyroiditis—a retrospective observational study of 370 patients

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1637 Open-access full textSource: OpenAlex

  13. EP1745 - LBA_ECE_1299 - An unusual presentation: panhypopituitarism and central diabetes insipidus revealing small cell lung cancer

    European Journal of Endocrinology, 2026

    DOI 10.1093/ejendo/lvag096.1801 Open-access full textSource: OpenAlex

  14. Thyroid carcinoma in Graves’ disease: a retrospective analysis of prevalence, histological subtypes, and clinical predictors

    BMC Endocrine Disorders, 2026

    DOI 10.1186/s12902-026-02413-9 Open-access full textSource: OpenAlex

  15. Temporal Variation of Biochemical Markers and Adenoma Predictors in Normocalcemic Primary Hyperparathyroidism: A Multicenter Retrospective Analysis

    Clinical Endocrinology, 2025

    DOI 10.1111/cen.70024 PMID 40891177 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  16. DİYABET TANI ve TEDAVİ REHBERİ

    Ataturk University - AVESIS, 2025

    Source: OpenAlex

  17. Clinical characteristics of Graves' disease following COVID-19 infection or vaccination: a multicenter case-control study

    Turkish journal of medical sciences, 2025

    DOI 10.55730/1300-0144.6096 PMID 41509944 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  18. Clinical characteristics, mid-term outcomes and management of asymptomatic primary hyperparathyroidism: A multicentre retrospective cohort study

    Endocrine, 2025

    DOI 10.1007/s12020-025-04380-y PMID 40790100 Open-access full textSource: OpenAlex

  19. An underdiagnosed manifestation: Mandibular bone loss in primary hyperparathyroidism

    Bone, 2025

    DOI 10.1016/j.bone.2025.117598 PMID 40769418 Source: ORCID

  20. Clinical outcomes and treatment adequacy assessment in congenital adrenal hyperplasia: A Single-Center experience with Long-Term Follow-Up

    Endocrine, 2025

    DOI 10.1007/s12020-025-04411-8 PMID 40903614 Source: ORCID

  21. Effects of vitamin D replacement combined with Graves' disease therapy: a retrospective cohort study

    Turkish Journal of Medical Sciences, 2025

    DOI 10.55730/1300-0144.5946 PMID 40104316 2 citations (Europe PMC) Open-access full textSource: ORCID

  22. Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas

    Pituitary, 2025

    DOI 10.1007/s11102-025-01512-5 PMID 40064718 5 citations (Europe PMC) Source: ORCID

  23. Importance of Hypomagnesemia in Primary Hyperparathyroidism: A Turkish Nationwide Retrospective Cohort Study

    Biological Trace Element Research, 2025

    DOI 10.1007/s12011-024-04481-1 PMID 39666169 Source: ORCID

  24. Machine Learning Prediction of Pancreatitis Risk With Antithyroid Drugs: A Nationwide Retrospective Observational Study

    The Journal of Clinical Endocrinology & Metabolism, 2025

    DOI 10.1210/clinem/dgae628 PMID 39324654 Source: ORCID

  25. Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer?

    Tumori Journal, 2025

    DOI 10.1177/03008916251334884 PMID 40462273 2 citations (Europe PMC) Source: ORCID

  26. Serum selenium levels and subacute thyroiditis: associations with disease course and long-term outcomes in a case-control study

    BMC Endocrine Disorders, 2025

    DOI 10.1186/s12902-025-01903-6 PMID 40102831 Open-access full textSource: ORCID

  27. The impact of hypophosphatemia on biochemical profile and renal outcomes in primary hyperparathyroidism: a nationwide retrospective study

    Turkish Journal of Medical Sciences, 2025

    DOI 10.55730/1300-0144.6095 PMID 41509939 1 citation (Europe PMC) Open-access full textSource: ORCID

  28. Early prolactin normalization and tumor shrinkage predict the first-year response to cabergoline treatment in invasive macro-giant prolactinomas

    Endocrine Abstracts, 2025

    DOI 10.1530/endoabs.110.p933 Source: OpenAlex

  29. Pioglitazone/Exenatide/SGLT-2 inhibitor combination therapy versus insulin therapy in patients with poorly controlled type 2 diabetes

    Anatolian Current Medical Journal, 2024

    DOI 10.38053/acmj.1415215 Open-access full textSource: ORCID

  30. Disrupted harmony of the skull skeleton: Middle ear resonance in acromegaly

    Growth Hormone and IGF Research, 2024

    DOI 10.1016/j.ghir.2024.101594 PMID 38833815 1 citation (Europe PMC) Source: ORCID

  31. Electrocardiographic ventricular arrhythmia parameters during diagnosis and after the treatment of acromegaly: A case-control study

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e38033 PMID 39398067 3 citations (Europe PMC) Open-access full textSource: ORCID

  32. Growth Differentiation Factor 15 in Patients with Acromegaly: A Case–Control Study

    Endocrinology Research and Practice, 2024

    DOI 10.5152/erp.2024.24424 Open-access full textSource: ORCID

  33. Hypomagnesemia may be associated with symptomatic disease in patients with primary hyperparathyroidism

    Endocrine, 2024

    DOI 10.1007/s12020-023-03577-3 PMID 37922091 9 citations (Europe PMC) Source: ORCID

  34. The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly

    Pituitary, 2024

    DOI 10.1007/s11102-023-01370-z PMID 38064149 6 citations (Europe PMC) Source: ORCID

  35. O-07 Lipodystrophy: A disease to be considered in diabetes clinics

    JCEM Case Reports, 2024

    DOI 10.1210/jcemcr/luad146.024 Open-access full textSource: OpenAlex

  36. Growth differentiation factor 15 in patients with acromegaly: a case-control study

    Endocrine Abstracts, 2024

    DOI 10.1530/endoabs.99.ep351 Source: OpenAlex

  37. The impact of SGLT2-inhibitor therapy on platelet function in type 2 Diabetes mellitus

    Journal of Health Sciences and Medicine, 2023

    DOI 10.32322/jhsm.1202548 Open-access full textSource: ORCID

  38. Impact of 24-week dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus

    Turkish Journal of Medical Sciences, 2023

    DOI 10.55730/1300-0144.5683 PMID 38813008 1 citation (Europe PMC) Open-access full textSource: ORCID

  39. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism

    Einstein (Sao Paulo, Brazil), 2023

    DOI 10.31744/einstein_journal/2023rc0229 PMID 37493833 Open-access full textSource: ORCID

  40. Real-time detection of acromegaly from facial images with artificial intelligence

    European Journal of Endocrinology, 2023

    DOI 10.1093/ejendo/lvad005 PMID 36747333 15 citations (Europe PMC) Source: ORCID

  41. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism

    Journal of Endocrinological Investigation, 2023

    DOI 10.1007/s40618-023-02064-w PMID 36929458 12 citations (Europe PMC) Source: ORCID

  42. Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study

    The Journal of clinical endocrinology and metabolism, 2023

    DOI 10.1210/clinem/dgad235 PMID 37186260 15 citations (Europe PMC) Open-access full textSource: Europe PMC

  43. SARS-COV-2 Aşısı ve Covid-19 ile ilişkili subakut tiroiditler: Ulusal çok merkezli çalışma (THYROVAC ÇALIŞMASI)

    Kocaeli Üniversitesi - AVESİS, 2023

    Source: OpenAlex

  44. Effect of thyroid nodule size on cytology reliability and incidence of malignancy: A large cohort of 1205 patients from a single center

    Annales d'Endocrinologie, 2023

    DOI 10.1016/j.ando.2022.08.002 PMID 36126756 5 citations (Europe PMC) Source: ORCID

  45. Impact of the COVID-19 pandemic on the incidence, seasonal distribution, and characteristics of subacute thyroiditis

    Endocrine, 2023

    DOI 10.1007/s12020-022-03197-3 PMID 36129593 10 citations (Europe PMC) Open-access full textSource: ORCID

  46. Prevalence and associated risk factors of simple renal cysts in primary hyperparathyroidism

    Hormones, 2023

    DOI 10.1007/s42000-022-00416-4 PMID 36319934 5 citations (Europe PMC) Source: ORCID

  47. Prevalence and related risk factors of simple renal cysts and nephrolithiasis in acromegaly

    Endocrine Abstracts, 2023

    DOI 10.1530/endoabs.90.p441 Source: OpenAlex

  48. SARS-COV-2 AŞISI VE COVİD-19 İLE İLİŞKİLİ SUBAKUT TROİDİTLER: ULUSAL ÇOK MERKEZLİ ÇALIŞMA (THYROVAC ÇALIŞMASI)

    AYBU AVESIS, 2023

    Source: OpenAlex

  49. Cushing’s syndrome due to adrenocorticotropic hormone-secreting metastatic neuroendocrine tumor of unknown primary origin: a case report and literature review

    Hormones, 2022

    DOI 10.1007/s42000-021-00316-z PMID 34478059 11 citations (Europe PMC) Open-access full textSource: ORCID

  50. Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature

    Archives of Endocrinology and Metabolism, 2022

    DOI 10.20945/2359-3997000000481 PMID 35612842 10 citations (Europe PMC) Open-access full textSource: ORCID